Effect of Acute Rhodiola Rosea Supplementation on Premenstrual Syndrome Symptoms in Female Martial Artists
Paper ID : 1323-SPORTCONGRESS (R1)
Authors
یاسمین یاراحمدی *, سید مرتضی طیبی, مینو باسامی
دانشگاه علامه طباطبائی
Abstract
Introduction: Premenstrual syndrome (PMS) with physical and psychological symptoms in the luteal phase disrupts the performance of female martial artists. This study investigated the effect of Rhodiola rosea (RR) supplementation on PMS symptoms using the Impo app for tracking the menstrual cycle and MyFitnessPal for controlling metabolism and physical activity, along with the PSST questionnaire.

Methods: In this quasi-experimental study with a pre-test and post-test design, 20 female martial artists (18-28 years old) were randomly divided into two groups: intervention (10 people) and control (10 people). The menstrual cycle was monitored with Impo (tracking period and PMS symptoms) and metabolism with MyFitnessPal (calculating BMR and tracking exercise). The intervention group consumed 500 mg of RR daily (containing 3% rosavin and 1% salidroside) for 10 days in the luteal phase (determined by Impo); the control group received a placebo. PMS symptoms were assessed with the PSST before and after the intervention and analyzed with analysis of covariance in SPSS (p < 0.05).

Findings: PSST data, supported by Impo and MyFitnessPal, showed a significant reduction in physical (bloating, breast tenderness, fatigue) and psychological (irritability, anxiety, mood swings) symptoms in the RR group (p < 0.05). The control group showed no significant change. The alleviation of moderate to severe symptoms in the RR group was consistent with the recorded data.

Conclusion: Consumption of 500 mg of RR for 10 days, with cycle tracking by Impo and metabolism tracking by MyFitnessPal, is an effective strategy for reducing PMS symptoms in female martial artists. Future research with a larger sample size is suggested.
Keywords
Premenstrual Syndrome, Rhodiola Rosea, Impo, MyFitnessPal, PSST, Fighting Women
Status: Abstract Accepted (Oral Presentation)